We are live on ! Find out more
INDV icon

Indivior Pharmaceuticals
INDV

60 hedge funds and large institutions have $1.86B invested in Indivior Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.95% more ownership

Funds ownership: 0% → 44.95% (+45%)

Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
0.94%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.08%
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSC
Two Seas Capital
New York
+$313M
2
SCM
Scopia Capital Management
New York
+$220M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$132M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$82.1M
5
Goldman Sachs
Goldman Sachs
New York
+$80.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Credit Suisse
Switzerland
$326M +$4.1M +178,788 New
TSC
2
Two Seas Capital
New York
$325M +$313M +13,668,919 New
SCM
3
Scopia Capital Management
New York
$228M +$220M +9,590,921 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$137M +$132M +5,755,681 New
Goldman Sachs
5
Goldman Sachs
New York
$83.7M +$80.6M +3,515,893 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$82.9M +$82.1M +3,582,107 New
MGIM
7
M&G Investment Management
United Kingdom
$74.2M +$735K +32,050 New
AIM
8
Artemis Investment Management
United Kingdom
$72.9M +$72.2M +3,151,563 New
PCH
9
Polar Capital Holdings
United Kingdom
$72.6M +$69.9M +3,049,687 New
Bank of America
10
Bank of America
North Carolina
$56.8M +$54.7M +2,386,915 New
Norges Bank
11
Norges Bank
Norway
$55.2M +$54.6M +2,383,774 New
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$54M +$53.4M +2,328,706 New
Toronto Dominion Bank
13
Toronto Dominion Bank
Ontario, Canada
$30.7M +$30.4M +1,325,865 New
Capital World Investors
14
Capital World Investors
California
$29.8M +$29.5M +1,284,920 New
JP Morgan Chase
15
JP Morgan Chase
New York
$23.1M +$22.2M +970,623 New
BFM
16
Boothbay Fund Management
New York
$21.9M +$21.7M +946,208 New
UBS Group
17
UBS Group
Switzerland
$19.7M +$18.9M +826,312 New
PFM
18
Premier Fund Managers
United Kingdom
$18.9M +$18.7M +816,679 New
AM
19
Anqa Management
New York
$18.7M +$18.5M +805,446 New
JAM
20
Jupiter Asset Management
United Kingdom
$15.3M +$15.1M +658,603 New
JFG
21
Jefferies Financial Group
New York
$13.6M +$13.4M +586,541 New
Mackenzie Financial
22
Mackenzie Financial
Ontario, Canada
$12.8M +$12.9M +560,686 New
Royal London Asset Management
23
Royal London Asset Management
United Kingdom
$10.7M +$10.3M +450,040 New
Barclays
24
Barclays
United Kingdom
$10.6M +$10.2M +446,713 New
Arrowstreet Capital
25
Arrowstreet Capital
Massachusetts
$10.6M +$10.5M +457,757 New
1
2 3

INDV Hedge Fund Activity: Q2 2023 in Review

60 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Indivior Pharmaceuticals (INDV) for Q2 2023, worth a combined $1.86B.

Buyers outnumbered sellers: 60 funds opened new INDV positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Two Seas Capital, opening a new position worth an estimated $313M.

  • 60 institutional investors held Indivior Pharmaceuticals (INDV) as of Q2 2023, up from 0 in Q1 2023.
  • Funds reported $1.86B of Indivior Pharmaceuticals stock for Q2 2023.
  • 60 funds opened new Indivior Pharmaceuticals positions in Q2 2023 and 0 closed out, a net change of +60 holders.
  • The largest Indivior Pharmaceuticals buyer in Q2 2023 was Two Seas Capital, an estimated $313M added.

Based on aggregated 13F filings for Q2 2023.